Heinrich Haas

Former VP at BioNTech SE
Heinrich gained his Ph.D. in the group of Prof. Dr. Helmuth Möhwald at Johannes-Gutenberg Universität Mainz. He researched lipid membranes and organized bio-molecular systems. In pharmaceutical industry (Munich Biotech, Medigene, BioNTech), he developed different types of nanoparticle products to clinical stage. Focus on advanced approaches for nanoparticle development and control.

Events/Masterclasses Heinrich Haas is currently speaking at

Pharma

Lipid Nanoparticles for Drug/mRNA Delivery
12 - 13 December 2023
Online Live Stream | 9:00 CET – 17:00 CET
After the successful development of lipid nanoparticles (LNPs) comprising messenger RNA (mRNA) for vaccination against Covid-19, the interest in mRNA and nanoparticle systems for various therapeutic applications has surged tremendously.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Heinrich Haas
Former VP at BioNTech SE
Company
Heinrich gained his Ph.D. in the group of Prof. Dr. Helmuth Möhwald at Johannes-Gutenberg Universität Mainz. He researched lipid membranes and organized bio-molecular systems. In pharmaceutical industry (Munich Biotech, Medigene, BioNTech), he developed different types of nanoparticle products to clinical stage. Focus on advanced approaches for nanoparticle development and control.
Heinrich Haas
Description